TNSN92115A1 - Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation - Google Patents

Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation

Info

Publication number
TNSN92115A1
TNSN92115A1 TNTNSN92115A TNSN92115A TNSN92115A1 TN SN92115 A1 TNSN92115 A1 TN SN92115A1 TN TNSN92115 A TNTNSN92115 A TN TNSN92115A TN SN92115 A TNSN92115 A TN SN92115A TN SN92115 A1 TNSN92115 A1 TN SN92115A1
Authority
TN
Tunisia
Prior art keywords
preparation
benzimidazoles
substitutes
compounds
intermediates
Prior art date
Application number
TNTNSN92115A
Other languages
English (en)
French (fr)
Inventor
Bjorn Christer Holstein Kark
Elisabeth Sunden Gunnel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN92115A1 publication Critical patent/TNSN92115A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TNTNSN92115A 1991-12-19 1992-12-18 Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation TNSN92115A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103776A SE9103776D0 (sv) 1991-12-19 1991-12-19 New compounds

Publications (1)

Publication Number Publication Date
TNSN92115A1 true TNSN92115A1 (fr) 1993-06-08

Family

ID=20384667

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN92115A TNSN92115A1 (fr) 1991-12-19 1992-12-18 Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation

Country Status (25)

Country Link
EP (1) EP0628049A1 (no)
JP (1) JPH07502503A (no)
KR (1) KR940703840A (no)
CN (1) CN1031827C (no)
AP (1) AP397A (no)
AU (1) AU665043B2 (no)
CA (1) CA2124689A1 (no)
CZ (1) CZ146794A3 (no)
FI (1) FI942912A0 (no)
HR (1) HRP921400A2 (no)
HU (1) HUT68270A (no)
IL (1) IL104025A0 (no)
IS (2) IS4079A (no)
MA (1) MA22746A1 (no)
MX (1) MX9207269A (no)
NO (1) NO942230D0 (no)
NZ (1) NZ246220A (no)
SE (1) SE9103776D0 (no)
SI (1) SI9200402A (no)
SK (1) SK73594A3 (no)
TN (1) TNSN92115A1 (no)
TW (1) TW224100B (no)
WO (1) WO1993012124A1 (no)
YU (1) YU101692A (no)
ZA (1) ZA928836B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19645974C1 (de) * 1996-11-07 1998-08-13 Andreas Johannes Kesel (Z)-5-[[3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylen]-2-thioxo-4- thiazolidinon, Verfahren zu dessen Herstellung und Verwendung
DE69822514T2 (de) * 1997-12-31 2005-03-24 The University Of Kansas, Lawrence Wasserlösliche pro-pharmaka von arzneistoffen, die ein tertiäres amin enthalten, und verfahren zu ihrer herstellung
US7893271B2 (en) 2005-07-28 2011-02-22 Intervet International B.V. Benzimidazole carbamates and (thio) carbamates, and the synthesis and use thereof
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
CA2660647C (en) 2006-06-14 2015-07-28 Intervet International B.V. A suspension comprising benzimidazole carbamate and a polysorbate
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
MX365051B (es) 2014-11-26 2019-05-09 Univ Mexico Nac Autonoma Nuevos compuestos hidrosolubles derivados del bencimidazol, utiles para el tratamiento de la fasciolosis.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
SE8801907D0 (sv) * 1988-05-20 1988-05-20 Haessle Ab Novel pharmacological compounds
PL166209B1 (pl) * 1990-06-20 1995-04-28 Astra Ab Sposób wytwarzania nowych pochodnych benzimidazolu PL
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds

Also Published As

Publication number Publication date
CA2124689A1 (en) 1993-06-24
ZA928836B (en) 1993-07-05
AP9200463A0 (en) 1993-01-31
SK73594A3 (en) 1995-02-08
JPH07502503A (ja) 1995-03-16
CN1031827C (zh) 1996-05-22
AP397A (en) 1995-08-14
SI9200402A (en) 1993-06-30
IS3960A (is) 1993-06-20
HUT68270A (en) 1995-06-28
SE9103776D0 (sv) 1991-12-19
AU3175293A (en) 1993-07-19
FI942912A (fi) 1994-06-17
MA22746A1 (fr) 1993-07-01
HRP921400A2 (en) 1994-08-31
FI942912A0 (fi) 1994-06-17
TW224100B (no) 1994-05-21
HU9401840D0 (en) 1994-09-28
NO942230L (no) 1994-06-14
KR940703840A (ko) 1994-12-12
EP0628049A1 (en) 1994-12-14
AU665043B2 (en) 1995-12-14
CN1073446A (zh) 1993-06-23
YU101692A (sh) 1995-10-03
WO1993012124A1 (en) 1993-06-24
CZ146794A3 (en) 1996-02-14
NO942230D0 (no) 1994-06-14
IS4079A (is) 1993-06-20
NZ246220A (en) 1996-02-27
MX9207269A (es) 1993-06-01
IL104025A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
UY23665A1 (es) Procedimiento para la preparacion de compuesto farmaceutico
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
HUP9902105A2 (hu) Angiosztatikus dipeptideket tartalmazó gyógyászati készítmények és ezek alkalmazása
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
FR2512670B1 (fr) Capsules contenant le principe actif d'un allergene et procede pour leur preparation
LV12766A (lv) Composition of l-dopa esters
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE180971T1 (de) Verwendung von fettsäureester als bioklebstoffe
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
RU94026283A (ru) Фармацевтическое соединение
ES8609325A1 (es) Un procedimiento para preparar derivados de guanina
ATE268605T1 (de) Pharmazeutische akzeptabel dnase zusammensetzung
TNSN92115A1 (fr) Succedanes de benzimidazoles, processus de leur preparation ainsi que de leur utilisation
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
HU911184D0 (en) Process for the production of medical preparations containing n-alkylized 1,4-dihydropirine-carbonic acid esthers and process for the production of such esthers
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
MD545G2 (ro) Preparat medicamentos
HUP9801759A2 (hu) Neurodegeneratív betegségek kezelésére alkalmas benzamidok
DE59108104D1 (de) Arzneimittel enthaltend cd14